Breaking News - Candlesense

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025

SOUTH SAN FRANCISCO, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing next-generation CAR T-cell therapies for patients w...

How might the market react to any disclosed adverse events or safety concerns in the trial data? What is the potential impact of any FDA Fast Track, Breakthrough, or other designations on the timeline? What are the potential implications of the trial's single‑arm design for regulatory approval?

Symbol: LYEL

Earnings

25 days ago

Read more globenewswire

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Strengthened balance sheet raising approximately $64 million in gross proceeds in July 2025; cash, cash equivalents, and short-term investments now sufficient to fund operations into the first half...

What are the implications for the company's capital structure and leverage ratios moving forward? Could the extended cash runway alter the company's strategic timeline or partnership opportunities? What is the market's perception of the balance sheet strengthening—does it reduce risk premiums for the stock?

Symbol: ABSI

Earnings

25 days ago

Read more globenewswire

Cue Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights

BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and...

How might the recent business highlights influence institutional sentiment and potential fund inflows or outflows? What potential regulatory or reimbursement risks could affect the company's upcoming product launches? Are there any forward‑looking guidance revisions (e.g., revenue, net loss, cash runway) that could influence analyst forecasts?

Symbol: CUE

Earnings

25 days ago

Read more globenewswire

Arbor Realty Trust Closes a $1.05 Billion Collateralized Loan Obligation Securitization

UNIONDALE, N.Y., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (NYSE: ABR), today announced the closing of a $1.05 billion commercial real estate mortgage loan securitization (the “S...

What are the tax implications of the securitization for ABR and its shareholders? How does the current market appetite for CRE mortgage-backed securities affect the pricing and demand for these notes? Will the retained subordinate interest expose ABR to increased downside risk if loan performance deteriorates?

Symbol: ABR

Financing

25 days ago

Read more globenewswire

Diginex Announces MOU for US$305m Acquisition of Findings, a leading cybersecurity and compliance automation company

LONDON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex” or the “Company”) (NASDAQ: DGNX), a leading provider of Sustainability RegTech solutions, today announced the signing of a non...

Will the acquisition expand Diginex's geographic footprint or client base, and how might that affect future growth prospects? What is the timeline for completing the transaction and any associated earn‑out or contingent payments? How does the market view Diginex's strategic shift toward cybersecurity and compliance automation?

Symbol: DGNX

Mergers

25 days ago

Read more globenewswire

ARRAY Technologies, Inc. to Participate in Upcoming Investor Conferences and Events

ALBUQUERQUE, N.M., Aug. 12, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products, software and se...

What are the broader market conditions that could amplify or mitigate the impact of these events on ARRY's stock? Are there any risks or downsides associated with the company's participation in these investor events? How might the events influence institutional investor activity in ARRY?

Symbol: ARRY

Investor events

25 days ago

Read more globenewswire

CNB Financial Corporation Announces Quarterly Dividend for Common Stock

CLEARFIELD, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of CNB Financial Corporation (Nasdaq: CCNE) declared a quarterly cash dividend of $0.18 per share of common stock payable...

What potential impact could this dividend have on the stock's total return profile for long‑term investors? Does the timing of the dividend payment suggest any strategic positioning ahead of upcoming earnings releases or market events? Are there any tax considerations or withholding implications for shareholders receiving this dividend?

Symbol: CCNE

Dividends

25 days ago

Read more globenewswire

Rigetti Computing Reports Second Quarter 2025 Financial Results; Announces General Availability of its 36-Qubit Multi-Chip Quantum Computer

BERKELEY, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced its ...

How might the release of the 36‑qubit system influence the valuation multiples (e.g., P/E, EV/EBITDA) that traders use to price the stock? What macro‑economic or sector‑specific risks might offset the positive news and influence the stock’s upside potential? Are there any changes to the company’s capital‑expenditure plans or cash‑flow outlook that could affect its balance sheet stability?

Symbol: RGTI

Earnings

25 days ago

Read more globenewswire

Rekor Systems Reports Second Quarter 2025 Financial Results

Second Quarter Results Strengthen Position as AI Leader in Roadway Intelligence Second Quarter Results Strengthen Position as AI Leader in Roadway Intelligence

How will the Q2 results impact institutional and retail investor positioning in REKR? Is there any insider buying or selling activity following the release that could signal market sentiment? What risks or uncertainties were disclosed in the earnings release that could affect the stock?

Symbol: REKR

Earnings

25 days ago

Read more globenewswire

ImmuCell Announces Bank Debt Refinancing

PORTLAND, Maine, Aug. 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scien...

How might the refinancing influence the stock's valuation multiples (e.g., P/E, EV/EBITDA) relative to industry peers? Is there any impact on the company's dividend policy or share repurchase plans due to the debt refinancing? Will the refinancing have any immediate effect on the company's earnings per share (EPS) guidance or profitability forecasts?

Symbol: ICCC

Finance

25 days ago

Read more globenewswire